Cantor Fitzgerald Weighs in on ARWR FY2026 Earnings
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of Arrowhead Pharmaceuticals in a report released on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal anticipates that the biotechnology company will post earnings per share of ($4.72) for the year. The consensus […]
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of Arrowhead Pharmaceuticals in a report released on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal anticipates that the biotechnology company will post earnings per share of ($4.72) for the year. The consensus […]
